The Dana Foundation, established in 1950 by the industrialist, philanthropist, and legislator Charles A. Dana, is a private philanthropic foundation with principal interests in science, health, and education. The Foundation’s current area of research emphasis is in neuroscience. Selected proposals have the potential to improve human health or functioning.
- Supports programs in science, health, and education through specifically defined objectives in each field.
- Requires grantee institutions, in many cases, to share the cost of a project or raise matching funds.
- Makes no grants directly to individuals.
- Does not support annual operating costs of organizations, deficit reduction, capital campaigns, or individual sabbaticals.
- Does not schedule meetings with applicants, other than by specific invitation initiated by the Foundation.
The David Mahoney Neuroimaging Program. Investigators use physiological and structural, cellular and molecular imaging techniques to pilot-test novel clinical hypotheses on the brain or interactions between brain and immune cells. Requests for Proposals (RFPs) are sent annually to deans of U.S. Medical Schools and other invited biomedical research institutions.
Clinical Neuroscience Research. Translational researchers apply to test promising therapies, from animal model research, in a small number of patients with devastating, currently untreatable, brain diseases. Also supported are studies to develop ethical guidelines for clinical brain research, and prognostic data based on treatment outcomes in patients with severe brain injuries or disorders.
All other Neuroscience Grants are made solely by invitation. For information, please contact:
Mary LucasGrants Office, The Dana Foundation505 Fifth Avenue, 6th floor
New York, NY 10017
(212) 223-4040 ext. 669